«
‹
1
...
5003
5004
5005
5006
5007
5008
5009
5010
5011
...
5099
›
»
Page 5007 of 5099 · 254917 entries
Go to
| PDB ID | Title | official curves | Structure unit | Experimental Method |
|---|---|---|---|---|
| 9ri3 | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9ri4 | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9ri5 | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9ri8 | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9ri9 | Cryo-EM structure of the tomato NRC3 hexameric resistosome | 1 | 1 | ELECTRON MICROSCOPY |
| 9ria | Cryo-EM structure of tomato NRC3-AVRcap1b complex | 1 | 1 | ELECTRON MICROSCOPY |
| 9rib | Crystal structure of C278S mutant of mouse CDC14A | 2 | 2 | X-RAY DIFFRACTION |
| 9rid | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9rif | The histone fold domain heterodimer of oocyst rupture proteins 1 and 2 from Plasmodium berghei | 6 | 6 | X-RAY DIFFRACTION |
| 9rig | EV-A71 (genotype B2) in complex with 16-2-9D Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9rih | EV-A71 (genotype B2) in complex with 16-2-12D Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9rii | EV-A71 (genotype B2) in complex with 34-1-6D Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9rij | EV-A71 (genotype B5) in complex with 16-2-8C Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9rik | EV-A71 (genotype B5) in complex with 16-2-2D Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9ril | EV-A71 (genotype B5) in complex with 16-3-3C Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9rim | EV-A71 (genotype B5) in complex with 16-3-4D Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9rin | EV-A71 (genotype B5) in complex with 17-1-12A Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9rio | EV-A71 (genotype B5) in complex with 17-2-2B Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9rip | EV-A71 (genotype B5) in complex with 17-2-12A Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9riq | EV-A71 (genotype C4) in complex with 16-2-11B Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9rir | EV-A71 (genotype C4) in complex with 16-3-10B Fab | 1 | 1 | ELECTRON MICROSCOPY |
| 9ris | Crystal structure of human IDO1 in complex with iDeg-1 | 1 | 1 | X-RAY DIFFRACTION |
| 9rit | Co-crystal of broadly neutralizing biparatopic VHH in complex with cardiotoxin (P01468) Naja pallida | 2 | 2 | X-RAY DIFFRACTION |
| 9riu | Co-crystal of broadly neutralizing VHH in complex with short neurotoxin 1 (P01426) Naja pallida | 2 | 2 | X-RAY DIFFRACTION |
| 9riv | Population B fibril generated from the Heterotypic interaction of Abeta40 and Medin. | 1 | 1 | ELECTRON MICROSCOPY |
| 9riw | Population A fibril generated from the Heterotypic interaction of Abeta40 and Medin. | 1 | 1 | ELECTRON MICROSCOPY |
| 9rix | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9riy | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9riz | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9rj0 | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9rj1 | S-methylcysteine synthase (BSAS4) from common bean in complex with PLP, BEZ, and GOL | 1 | 1 | X-RAY DIFFRACTION |
| 9rj3 | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9rj5 | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9rj7 | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9rj8 | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9rj9 | [FeFe]-hydrogenase CpI from Clostridium pasteurianum, variant N160L | 2 | 2 | X-RAY DIFFRACTION |
| 9rja | Manikomycin bound to the Escherichia coli 70S ribosome | 1 | 1 | ELECTRON MICROSCOPY |
| 9rjb | Human Signal Peptidase in complex with artificial Signal Peptide L11 | 1 | 1 | ELECTRON MICROSCOPY |
| 9rjc | Apo Structure of the Human Signal Peptidase | 1 | 1 | ELECTRON MICROSCOPY |
| 9rjf | SARS-CoV-2 with a bound inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 9rjg | Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin (compound 1) | 2 | 2 | X-RAY DIFFRACTION |
| 9rjh | Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin-derivative KV26a (compound 4) | 2 | 2 | X-RAY DIFFRACTION |
| 9rji | Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin-derivative KV29a (compound 5) | 2 | 2 | X-RAY DIFFRACTION |
| 9rjj | Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative KV37a (compound 9) | 2 | 2 | X-RAY DIFFRACTION |
| 9rjk | Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative KV41a (compound 11) | 1 | 1 | X-RAY DIFFRACTION |
| 9rjl | Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative KV35a (compound 12) | 2 | 2 | X-RAY DIFFRACTION |
| 9rjm | Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative EP196 (compound 13) | 2 | 2 | X-RAY DIFFRACTION |
| 9rjn | Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative KV32a (compound 14) | 1 | 1 | X-RAY DIFFRACTION |
| 9rjo | [FeFe]-hydrogenase CpI from Clostridium pasteurianum, variant N160L-Q195L | 2 | 2 | X-RAY DIFFRACTION |
| 9rjp | Structure of Mycobacterium tuberculosis InhA in complex with pyridomycin derivative KV25a (compound 15) | 1 | 1 | X-RAY DIFFRACTION |